Your browser doesn't support javascript.
loading
Efficacy and safety of relmacabtagene autoleucel, an anti-CD19 chimeric antigen receptor T cell, in relapsed/refractory B-cell non-Hodgkin's lymphoma: 2-year results of a phase 1 trial.
Ying, Zhitao; Xie, Yan; Zheng, Wen; Liu, Weiping; Lin, Ningjing; Tu, Meifeng; Wang, Xiaopei; Ping, Lingyan; Deng, Lijuan; Zhang, Chen; Wu, Meng; Feng, Feier; Du, Tingting; Tang, Yongjing; Su, Fang; Guo, Ziyu; Li, James; Song, Yuqin; Zhu, Jun.
Affiliation
  • Ying Z; Department of Lymphoma, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital & Institute, Beijing, 100142, China.
  • Xie Y; Department of Lymphoma, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital & Institute, Beijing, 100142, China.
  • Zheng W; Department of Lymphoma, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital & Institute, Beijing, 100142, China.
  • Liu W; Department of Lymphoma, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital & Institute, Beijing, 100142, China.
  • Lin N; Department of Lymphoma, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital & Institute, Beijing, 100142, China.
  • Tu M; Department of Lymphoma, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital & Institute, Beijing, 100142, China.
  • Wang X; Department of Lymphoma, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital & Institute, Beijing, 100142, China.
  • Ping L; Department of Lymphoma, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital & Institute, Beijing, 100142, China.
  • Deng L; Department of Lymphoma, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital & Institute, Beijing, 100142, China.
  • Zhang C; Department of Lymphoma, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital & Institute, Beijing, 100142, China.
  • Wu M; Department of Lymphoma, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital & Institute, Beijing, 100142, China.
  • Feng F; Department of Lymphoma, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital & Institute, Beijing, 100142, China.
  • Du T; Department of Lymphoma, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital & Institute, Beijing, 100142, China.
  • Tang Y; Department of Lymphoma, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital & Institute, Beijing, 100142, China.
  • Su F; JW Therapeutics (Shanghai) Co., Ltd, Shanghai, 201210, China.
  • Guo Z; JW Therapeutics (Shanghai) Co., Ltd, Shanghai, 201210, China.
  • Li J; JW Therapeutics (Shanghai) Co., Ltd, Shanghai, 201210, China.
  • Song Y; Department of Lymphoma, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital & Institute, Beijing, 100142, China. songyuqin622@outlook.com.
  • Zhu J; Department of Lymphoma, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital & Institute, Beijing, 100142, China. zhu-jun2017@outlook.com.
Bone Marrow Transplant ; 58(3): 288-294, 2023 03.
Article in En | MEDLINE | ID: mdl-36477110
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, Follicular / Lymphoma, Large B-Cell, Diffuse / Receptors, Chimeric Antigen Limits: Humans Language: En Journal: Bone Marrow Transplant Journal subject: TRANSPLANTE Year: 2023 Document type: Article Affiliation country: China
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, Follicular / Lymphoma, Large B-Cell, Diffuse / Receptors, Chimeric Antigen Limits: Humans Language: En Journal: Bone Marrow Transplant Journal subject: TRANSPLANTE Year: 2023 Document type: Article Affiliation country: China